Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease
Status:
Recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
In clinical trials of preclinical pharmacodynamic studies, Wei Li Bai capsules has been
proved to significantly improve the learning and memory ability of Alzheimer's disease model.
In this study, the researchers will use a multicenter, randomized, double-blind,
placebo-controlled parallel method to recruit Alzheimer's disease patients to confirm the
efficacy and safety of Wei Li Bai capsules. Confirmation of drug efficacy will be observed
through changes in Alzheimer's disease patients' general cognitive function scores, scores of
different cognitive domains, daily living activities, and symptom severities.